145 related articles for article (PubMed ID: 15859325)
1. [Screening of TACE peptide inhibitors from a phage display random 15-peptide library by recombinant TACE ecotodomain].
Huang W; Li LB; Han L; Zhang H; Yang YZ
Sheng Wu Gong Cheng Xue Bao; 2005 Jan; 21(1):30-5. PubMed ID: 15859325
[TBL] [Abstract][Full Text] [Related]
2. Screening of TACE peptide inhibitors from phage display peptide library.
Huang W; Li L; Han L; Yang Y
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):473-6. PubMed ID: 16463648
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of proliferation, adhesion and invasion ability of human lung carcinoma cell A549 by tumor necrosis factor-alpha converting enzyme (TACE)].
Yan Y; Li XO; Zhang J; Huang W; Li LB; Yang YZ
Sheng Wu Gong Cheng Xue Bao; 2007 Jul; 23(4):584-8. PubMed ID: 17822026
[TBL] [Abstract][Full Text] [Related]
4. The study of the inhibition of the recombinant TACE prodomain to endotoxemia in mice.
Li X; Yan Y; Huang W; Yang Y
Int J Mol Sci; 2009 Dec; 10(12):5442-5454. PubMed ID: 20054479
[TBL] [Abstract][Full Text] [Related]
5. The regulation of TACE catalytic function by its prodomain.
Li X; Yan Y; Huang W; Yang Y; Wang H; Chang L
Mol Biol Rep; 2009 Apr; 36(4):641-51. PubMed ID: 18386160
[TBL] [Abstract][Full Text] [Related]
6. Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases.
Hiraoka Y; Yoshida K; Ohno M; Matsuoka T; Kita T; Nishi E
Biochem Biophys Res Commun; 2008 May; 370(1):154-8. PubMed ID: 18355445
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the cDNA and gene for mouse tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25.
Cerretti DP; Poindexter K; Castner BJ; Means G; Copeland NG; Gilbert DJ; Jenkins NA; Black RA; Nelson N
Cytokine; 1999 Aug; 11(8):541-51. PubMed ID: 10433800
[TBL] [Abstract][Full Text] [Related]
8. Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha).
Hinkle CL; Mohan MJ; Lin P; Yeung N; Rasmussen F; Milla ME; Moss ML
Biochemistry; 2003 Feb; 42(7):2127-36. PubMed ID: 12590602
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in peripheral blood mononuclear cells in patients with advanced congestive heart failure.
Satoh M; Iwasaka J; Nakamura M; Akatsu T; Shimoda Y; Hiramori K
Eur J Heart Fail; 2004 Dec; 6(7):869-75. PubMed ID: 15556048
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion.
Solomon KA; Pesti N; Wu G; Newton RC
J Immunol; 1999 Oct; 163(8):4105-8. PubMed ID: 10510344
[TBL] [Abstract][Full Text] [Related]
11. Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?
Sharma M; Mohapatra J; Acharya A; Deshpande SS; Chatterjee A; Jain MR
Eur J Pharmacol; 2013 Feb; 701(1-3):106-13. PubMed ID: 23266381
[TBL] [Abstract][Full Text] [Related]
12. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening.
Chen Y; Diener K; Patel IR; Kawooya JK; Martin GA; Yamdagni P; Zhang X; Sandrasalphaa A; Sahasrabudhe S; Busch SJ
J Biomol Screen; 2002 Oct; 7(5):433-40. PubMed ID: 14599359
[TBL] [Abstract][Full Text] [Related]
13. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17).
Qiu Z; Yan M; Li Q; Liu D; Van den Steen PE; Wang M; Opdenakker G; Hu J
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):533-40. PubMed ID: 21827363
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
[TBL] [Abstract][Full Text] [Related]
15. Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.
Wu D; Gu Q; Zhao N; Xia F; Li Z
J Drug Target; 2015 Dec; 23(10):936-42. PubMed ID: 26061299
[TBL] [Abstract][Full Text] [Related]
16. Unlike for human monocytes after LPS activation, release of TNF-α by THP-1 cells is produced by a TACE catalytically different from constitutive TACE.
Moreira-Tabaka H; Peluso J; Vonesch JL; Hentsch D; Kessler P; Reimund JM; Dumont S; Muller CD
PLoS One; 2012; 7(3):e34184. PubMed ID: 22479555
[TBL] [Abstract][Full Text] [Related]
17. The P2/P2' sites affect the substrate cleavage of TNF-α converting enzyme (TACE).
Liu S; Liu S; Wang Y; Liao Z
Mol Immunol; 2014 Nov; 62(1):122-8. PubMed ID: 24980871
[TBL] [Abstract][Full Text] [Related]
18. [Preparation and identification of a single chain antibody against the shedding site of N-cadherin cleaved by ADAM10].
Li X; Huang W; Li L; Zhou L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):949-52. PubMed ID: 24011157
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha.
Patel IR; Attur MG; Patel RN; Stuchin SA; Abagyan RA; Abramson SB; Amin AR
J Immunol; 1998 May; 160(9):4570-9. PubMed ID: 9574564
[TBL] [Abstract][Full Text] [Related]
20. Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiation.
Wang Y; Sul HS
Mol Cell Biol; 2006 Jul; 26(14):5421-35. PubMed ID: 16809777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
